Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas

Leukemia and Lymphoma

Volumn 52, Issue 7, 2011, Pages 1321-1335

  Thomas, Rachael ^a   Seiser, Eric L ^a   Motsinger Reif, Alison ^a,b   Borst, Luke ^a   Valli, Victor E ^c   Kelley, Kathryn ^a   Suter, Steven E ^a,b   Argyle, David ^d   Burgess, Kristine ^e   Bell, Jerold ^e   Lindblad Toh, Kerstin ^f,g   Modiano, Jaime F ^h,i   Breen, Matthew ^a,b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c VDX VETERINARY DIAGNOSTICS   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e TUFTS UNIVERSITY   (United States)

^f UPPSALA UNIVERSITY   (Sweden)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

canine; chromosome; Comparative genomic hybridization (CGH); lymphoma; microarray

Indexed keywords

ANEUPLOIDY; ANIMAL TISSUE; ARTICLE; CHROMOSOME 13; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DOG; GENETIC VARIABILITY; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL;

ANEUPLOIDY; ANIMALS; BREEDING; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA COPY NUMBER VARIATIONS; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN;

EID: 79959592516     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.559802     Document Type: Article

References (63)

1. Bernheim A. Cytogenomics of cancers: from chromosome to sequence. Mol Oncol 2010;4:309-322.
2. Chan WJ. Pathogenesis of diffuse large B cell lymphoma. Int J Hematol 2010;92:219-230.
3. Jevremovic D, Viswanatha DS. Molecular diagnosis of hematopoietic and lymphoid neoplasms. Hematol Oncol Clin North Am 2009;23:903-933.
4. Modiano JF, Breen M, Valli VE, Wojcieszyn JW, Cutter GR. Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma. Leukemia 2007;21:184-187. (Pubitemid 44921856)
5. Shearin A, Ostrander EA. Leading the way: canine models of genomics and disease. Dis Model Mech 2010;3:27-34.
6. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107: 265-276. (Pubitemid 43053551)
7. American Kennel Club. The complete dog book. New York: Ballantine Books; 2006.
8. Parker HG, Kim LV, Sutter NB, et al. Genetic structure of the purebred domestic dog. Science 2004;304:1160-1164. (Pubitemid 38661853)
9. Modiano JF, Breen M, Burnett RC, et al. Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Res 2005;65: 5654-5661. (Pubitemid 40911166)
10. Lurie DM, Lucroy MD, Griffey SM, Simonson E, Madewell BR. T-cell-derived malignant lymphoma in the boxer breed. Vet Comp Oncol 2004;2:171-175.
11. Pastor M, Chalvet-Monfray K, Marchal T, et al. Genetic and environmental risk indicators in canine non-Hodgkin's lymphomas: breed associations and geographic distribution of 608 cases diagnosed throughout France over 1 year. J Vet Intern Med 2009;23:301-310.
12. Onions DE. A prospective survey of familial canine lymphosarcoma. J Natl Cancer Inst 1984;72:909-912.
13. Lobetti RG. Lymphoma in 3 related Rottweilers from a single household. J S Afr Vet Assoc 2009;80:103-105.
14. Breen M. Canine cytogenetics-from band to basepair. Cytogenet Genome Res 2008;120:50-60.
15. Derrien T, Andre C, Galibert F, Hitte C. Analysis of the unassembled part of the dog genome sequence: chromosomal localization of 115 genes inferred from multispecies comparative genomics. J Hered 2007;98:461-467. (Pubitemid 47357583)
16. American Kennel Club 2009 Dog Registration Statistics [Internet]. [Cited 18 October 2010]. Available from:
17. Jaffee E, Harris N, Stein H, Vardiman J. World Health Organization classification of tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001.
18. Valli VE. Veterinary pathologists achieve 80% agreement in application of WHO diagnoses to canine lymphoma. Cancer Ther 2008;6:221-226.
19. Thomas R, Duke SE, Karlsson EK, et al. A genome assembly-integrated dog 1 Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysis. Cytogenet Genome Res 2008;122: 110-121.
20. Lindblad-Toh K, Wade CM, Mikkelsen TS, et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005;438:803-819. (Pubitemid 41753059)
21. Tagawa H, Suguro M, Tsuzuki S, et al. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood 2005;106:1770-1777. (Pubitemid 41208593)
22. Takeuchi I, Tagawa H, Tsujikawa A, et al. The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis. Haematologica 2009;94:61-69.
23. Nakagawa M, Nakagawa-Oshiro A, Karnan S, et al. Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia/lymphoma. Clin Cancer Res 2009;15:30-38.
24. Chen W, Houldsworth J, Olshen AB, et al. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood 2006;107:2477-2485. (Pubitemid 43345571)
25. Oudejans JJ, van Wieringen WN, Smeets SJ, et al. Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics. Genes Chromosomes Cancer 2009;48:250-260.
26. Futreal PA, Coin L, Marshall M, et al. A census of human cancer genes. Nat Rev Cancer 2004;4:177-183. (Pubitemid 38337497)
27. Mitelman Database of Chromosome Aberrations in Cancer. 2005 [Internet]. [Cited November 2010]. Available from:
28. Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. 2010 [Internet]. [Cited November 2010]. Available from:
29. Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol 2005;87:163-208. (Pubitemid 41135900)
30. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511. (Pubitemid 30082188)
31. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005;105:1851-1861. (Pubitemid 40731764)
32. Bea S, Colomo L, Lopez-Guillermo A, et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol 2004;22:3498-3506. (Pubitemid 41103656)
33. Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005;106:3183-3190. (Pubitemid 41565917)
34. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-282. (Pubitemid 38029949)
35. Chang CC, McClintock S, Cleveland RP, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large Bcell lymphoma. Am J Surg Pathol 2004;28:464-470. (Pubitemid 38436519)
36. Hartmann EM, Ott G, Rosenwald A. Molecular biology and genetics of lymphomas. Hematol Oncol Clin North Am 2008;22:807-823, vii.
37. Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008;105:13520-13525.
38. Chen Y, Han T, Iqbal J, et al. Diffuse large B-cell lymphoma in Chinese patients: immunophenotypic and cytogenetic analyses of 124 cases. Am J Clin Pathol 2010;133:305-313.
39. Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M. Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer 2003;89:1530-1537. (Pubitemid 37386611)
40. Bauer TR Jr, McDermid HE, Budarf ML, Van Keuren ML, Blomberg BB. Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2. Immunogenetics 1993;38:387-399. (Pubitemid 23290965)
41. Arun SS, Breuer W, Hermanns W. Immunohistochemical examination of light-chain expression (lambda/kappa ratio) in canine, feline, equine, bovine and porcine plasma cells. Zentralbl Veterinarmed A 1996;43:573-576. (Pubitemid 126485786)
42. Novara F, Arcaini L, Merli M, et al. High-resolution genomewide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma. Hum Pathol 2009;40:1628-1637.
43. Seto M, Honma K, Nakagawa M. Diversity of genome profiles in malignant lymphoma. Cancer Sci 2010;101:573-578.
44. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110: 695-708. (Pubitemid 47105409)
45. Seelig DM, Avery PR, Kisseberth WC, Modiano JF. T cell lymphoproliferative diseases. In: Weiss DJ, Wardrop KJ, editors. Schalm's veterinary hematology. 6th ed. Hoboken, NJ: Wiley-Blackwell; 2010. Chapter 72 pp 525-539.
46. Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002;13:140-149. (Pubitemid 34436738)
47. Zettl A, Rudiger T, Konrad MA, et al. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 2004;164:1837-1848. (Pubitemid 38529786)
48. Nelson M, Horsman DE, Weisenburger DD, et al. Cytogenetic abnormalities and clinical correlations in peripheral Tcell lymphoma. Br J Haematol 2008;141:461-469. (Pubitemid 351565676)
49. Thorns C, Bastian B, Pinkel D, et al. Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach. Genes Chromosomes Cancer 2007;46:37-44. (Pubitemid 44772870)
50. Fosmire SP, Thomas R, Jubala CM, et al. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet Pathol 2007;44:467-478. (Pubitemid 47037807)
51. Vose JM. Peripheral T-cell non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 2008;22:997-1005, x.
52. Campbell LJ. Cytogenetics of lymphomas. Pathology 2005;37:493-507. (Pubitemid 43030872)
53. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005;5:251-262. (Pubitemid 40488631)
54. Hunt KE, Reichard KK. Diffuse large B-cell lymphoma. Arch Pathol Lab Med 2008;132:118-124.
55. Strefford JC, An Q, Harrison CJ. Modeling the molecular consequences of unbalanced translocations in cancer: lessons from acute lymphoblastic leukemia. Cell Cycle 2009;8:2175-2184.
56. Breen M, Modiano JF. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans - man and his best friend share more than companionship. Chromosome Res 2008;16:145-154. (Pubitemid 351294788)
57. Stasik CJ, Nitta H, Zhang W, et al. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica 2010;95:597-603.
58. Thomas R, Duke SE, Wang HJ, et al. 'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors. J Neurooncol 2009;94:333-349.
59. Thomas R, Wang HJ, Tsai PC, et al. Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma. Chromosome Res 2009;17:365-377.
60. Dunn KA, Thomas R, Binns MM, Breen M. Comparative genomic hybridization (CGH) in dogs-application to the study of a canine glial tumour cell line. Vet J 2000;160:77-82.
61. Winkler S, Reimann-Berg N, Escobar HM, et al. Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer. Cancer Genet Cytogenet 2006;169:154-158. (Pubitemid 44287101)
62. Murphy WJ, Larkin DM, Everts-van der Wind A, et al. Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps. Science 2005;309:613-617. (Pubitemid 41033645)
63. Balhorn RL, Skorupski KA, Hok S, Balhorn MC, Guerrero T, Rebhun RB. A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non- Hodgkin's lymphoma also binds to canine B-cell lymphomas. Vet Immunol Immunopathol 2010;137:235-242.